{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:32:16Z","timestamp":1791462736454,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1053\/j.ajkd.2025.11.014","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:14:31Z","timestamp":1774311271000},"page":"788-798.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cancer Incidence in People With Glomerular Disease: A Population-Level Study"],"prefix":"10.1053","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5731-8974","authenticated-orcid":false,"given":"Jialin","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Canney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinshan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Atiquzzaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeera","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean J.","family":"Barbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2025.11.014_bib1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.semcancer.2019.06.005","article-title":"Autoimmune diseases and hematological malignancies: exploring the underlying mechanisms from epidemiological evidence","volume":"64","author":"Hemminki","year":"2020","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"10.1053\/j.ajkd.2025.11.014_bib2","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/ijc.24141","article-title":"Autoimmunity and lymphomagenesis","volume":"124","author":"Goldin","year":"2009","journal-title":"Int J Cancer"},{"issue":"6917","key":"10.1053\/j.ajkd.2025.11.014_bib3","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"issue":"11","key":"10.1053\/j.ajkd.2025.11.014_bib4","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3390\/biom9110735","article-title":"Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements","volume":"9","author":"Aggarwal","year":"2019","journal-title":"Biomolecules"},{"issue":"3","key":"10.1053\/j.ajkd.2025.11.014_bib5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0300-483X(02)00612-1","article-title":"Immunosuppressive drugs and cancer","volume":"185","author":"Vial","year":"2003","journal-title":"Toxicology"},{"issue":"8","key":"10.1053\/j.ajkd.2025.11.014_bib6","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/rheumatology\/keu372","article-title":"Prolonged risk of specific malignancies following cyclophosphamide therapy among patients with granulomatosis with polyangiitis","volume":"54","author":"Faurschou","year":"2015","journal-title":"Rheumatology"},{"issue":"5","key":"10.1053\/j.ajkd.2025.11.014_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0090-4295(91)80228-Y","article-title":"Cyclophosphamide-associated carcinoma of urothelium: modalities for prevention","volume":"38","author":"Cannon","year":"1991","journal-title":"Urology"},{"issue":"9173","key":"10.1053\/j.ajkd.2025.11.014_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(99)06154-1","article-title":"Cancer in patients on dialysis for end-stage renal disease: an international collaborative study","volume":"354","author":"Maisonneuve","year":"1999","journal-title":"Lancet"},{"issue":"3","key":"10.1053\/j.ajkd.2025.11.014_bib9","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2215\/CJN.14570920","article-title":"De novo malignancies after kidney transplantation","volume":"17","author":"Al-Adra","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2025.11.014_bib10","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.ajkd.2014.12.013","article-title":"Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996-2009","volume":"65","author":"Butler","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.ajkd.2025.11.014_bib11","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/ndt\/gfad261","article-title":"Are patients with primary glomerular disease at increased risk of malignancy?","volume":"39","author":"Han","year":"2023","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2025.11.014_bib12","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1523-1755.2003.00771.x","article-title":"Glomerulonephritis and malignancy: a population-based analysis","volume":"63","author":"Birkeland","year":"2003","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2025.11.014_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12882-018-0828-2","article-title":"Quantification of cancer risk in glomerulonephritis","volume":"19","author":"Heaf","year":"2018","journal-title":"BMC Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2025.11.014_bib14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12882-020-01882-x","article-title":"Cancer development and mortality differences in patients with glomerulonephritis after renal biopsy: a single center retrospective cohort study","volume":"21","author":"Ryu","year":"2020","journal-title":"BMC Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2025.11.014_bib15","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1681\/ASN.2007060712","article-title":"Association of albuminuria and cancer incidence","volume":"19","author":"J\u00f8rgensen","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2025.11.014_bib16","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/aje\/kwaa043","article-title":"Albuminuria, kidney function, and cancer risk in the community","volume":"189","author":"Mok","year":"2020","journal-title":"Am J Epidemiol"},{"issue":"10","key":"10.1053\/j.ajkd.2025.11.014_bib17","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1681\/ASN.2013060604","article-title":"CKD and the risk of incident cancer","volume":"25","author":"Lowrance","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2025.11.014_bib18","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2215\/CJN.10820918","article-title":"Estimated glomerular filtration rate and the risk of cancer","volume":"14","author":"Xu","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2025.11.014_bib19","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2025.11.014_bib20","series-title":"Discharge abstract database (hospital separations). V2","year":"2016"},{"key":"10.1053\/j.ajkd.2025.11.014_bib21","series-title":"2022: Consolidation file (MSP registration & premium billing). V2","year":"2022"},{"key":"10.1053\/j.ajkd.2025.11.014_bib22","series-title":"PharmaNet. V2","year":"2023"},{"key":"10.1053\/j.ajkd.2025.11.014_bib23","series-title":"Vital statistics births. University of British Colombia","year":"2023"},{"key":"10.1053\/j.ajkd.2025.11.014_bib24","series-title":"BC Cancer Registry Data. V2","year":"2023"},{"issue":"5","key":"10.1053\/j.ajkd.2025.11.014_bib25","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.kint.2016.06.020","article-title":"The relatively poor correlation between random and 24-hour urine protein excretion in patients with biopsy-proven glomerular diseases","volume":"90","author":"Hogan","year":"2016","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2025.11.014_bib26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2215\/CJN.08060719","article-title":"Socioeconomic position and incidence of glomerular diseases","volume":"15","author":"Canney","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2025.11.014_bib27","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1053\/j.ajkd.2022.04.005","article-title":"The risk of cardiovascular events in individuals with primary glomerular diseases","volume":"80","author":"Canney","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"19","key":"10.1053\/j.ajkd.2025.11.014_bib28","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C\u2013based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2025.11.014_bib29","series-title":"Treatment of end-stage organ failure in Canada, Canadian Organ Replacement Register, 2009 to 2018: end-stage kidney disease and kidney transplants data tables","year":"2019"},{"issue":"1","key":"10.1053\/j.ajkd.2025.11.014_bib30","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1038\/s41467-018-05467-z","article-title":"Evaluating intrinsic and non-intrinsic cancer risk factors","volume":"9","author":"Wu","year":"2018","journal-title":"Nat Commun"},{"issue":"10","key":"10.1053\/j.ajkd.2025.11.014_bib31","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.molmed.2016.08.001","article-title":"Intrinsic versus extrinsic cancer risk factors and aging","volume":"22","author":"Podolskiy","year":"2016","journal-title":"Trends Mol Med"},{"issue":"1","key":"10.1053\/j.ajkd.2025.11.014_bib32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/jrms.jrms_267_22","article-title":"The tangled web of dyslipidemia and cancer: is there any association?","volume":"27","author":"Neshat","year":"2022","journal-title":"J Res Med Sci"},{"issue":"4","key":"10.1053\/j.ajkd.2025.11.014_bib35","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.ajkd.2017.03.018","article-title":"Kidney function, proteinuria, and cancer incidence: the Korean Heart Study","volume":"70","author":"Mok","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2025.11.014_bib36","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/annrheumdis-2012-202099","article-title":"Lymphoma risk in systemic lupus: effects of disease activity versus treatment","volume":"73","author":"Bernatsky","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1053\/j.ajkd.2025.11.014_bib37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/ncprheum0620","article-title":"B-cell lymphoproliferation in chronic inflammatory rheumatic diseases","volume":"3","author":"Hansen","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"2","key":"10.1053\/j.ajkd.2025.11.014_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.bj.2023.100638","article-title":"Immunosenescence, gut dysbiosis, and chronic kidney disease: Interplay and implications for clinical management","volume":"47","author":"Lee","year":"2024","journal-title":"Biomed J"},{"issue":"3","key":"10.1053\/j.ajkd.2025.11.014_bib39","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.21675","article-title":"Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis","volume":"54","author":"Baecklund","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1053\/j.ajkd.2025.11.014_bib40","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1038\/ajg.2009.760","article-title":"Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies","volume":"105","author":"Pedersen","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1053\/j.ajkd.2025.11.014_bib41","first-page":"375","article-title":"Lung cancer in non-smokers","volume":"117","author":"Dubin","year":"2020","journal-title":"Mo Med"},{"issue":"5","key":"10.1053\/j.ajkd.2025.11.014_bib42","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/art.30296","article-title":"Incidence and predictors of urotoxic adverse events in cyclophosphamide-treated patients with systemic necrotizing vasculitides","volume":"63","author":"Le Guenno","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1053\/j.ajkd.2025.11.014_bib43","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1128\/CMR.00124-13","article-title":"Viruses and human cancers: a long road of discovery of molecular paradigms","volume":"27","author":"White","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"10.1053\/j.ajkd.2025.11.014_bib44","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13590","article-title":"Human papillomavirus infection in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Chin-Hong","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1053\/j.ajkd.2025.11.014_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1112513","article-title":"Human papillomavirus in the setting of immunodeficiency: pathogenesis and the emergence of next-generation therapies to reduce the high associated cancer risk","volume":"14","author":"Hewavisenti","year":"2023","journal-title":"Front Immunol"},{"issue":"4","key":"10.1053\/j.ajkd.2025.11.014_bib46","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/pds.3953","article-title":"Identification of smoking using Medicare data\u2014a validation study of claims-based algorithms: smoking algorithm validation in Medicare claims","volume":"25","author":"Desai","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638626007596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638626007596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T23:24:50Z","timestamp":1781825090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638626007596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0272638626007596"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2025.11.014","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer Incidence in People With Glomerular Disease: A Population-Level Study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2025.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}